Philipp Blanke, MD, a Jonathan R. Weir-McCall, MBCHB, PHD, b Stephan Achenbach, MD,
c Victoria Delgado, MD, PHD, d Jörg Hausleiter, MD, e Hasan Jilaihawi, MD, f Mohamed …

Multimorbidity occurs in adults of all ages, but the number and complexity of comorbid
conditions commonly increase with advancing age such that cardiovascular disease (CVD) …

Background Previous trials have shown that among high-risk patients with aortic stenosis,
survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical …

Summary Background The Placement of Aortic Transcatheter Valves (PARTNER) trial
showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter …

Background We compared transcatheter aortic-valve replacement (TAVR), using a self-
expanding transcatheter aortic-valve bioprosthesis, with surgical aortic-valve replacement in …

Background: Transcatheter aortic valve replacement (TAVR) is being increasingly performed
in patients with bicuspid aortic valve stenosis (AS). Objectives: This study sought to compare …

Background Based on the early results of the Placement of Aortic Transcatheter Valves
(PARTNER) trial, transcatheter aortic valve replacement (TAVR) is an accepted treatment for …

Importance Transcatheter aortic valve replacement (TAVR) indications are expanding,
leading to an increasing number of patients with bicuspid aortic stenosis undergoing TAVR …

Background: Transcatheter aortic valve replacement (TAVR) is standard therapy for patients
with severe aortic stenosis who are at high surgical risk. However, national data regarding …

Abstract Background: The Society of Thoracic Surgeons (STS)/American College of
Cardiology Transcatheter Valve Therapy (TVT) Registry captures all procedures with Food …